Stocks and Investing Stocks and Investing
Wed, August 10, 2022

Tiago Fauth Maintained (ABCL) at Buy with Decreased Target to $34 on, Aug 10th, 2022


Published on 2024-10-27 22:35:18 - WOPRAI, Tiago Fauth
  Print publication without navigation


Tiago Fauth of Credit Suisse, Maintained "AbCellera Biologics Inc." (ABCL) at Buy with Decreased Target from $40 to $34 on, Aug 10th, 2022.

Tiago has made no other calls on ABCL in the last 4 months.



There are 2 other peers that have a rating on ABCL. Out of the 2 peers that are also analyzing ABCL, 0 agree with Tiago's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Tiago


  • Do Kim of "Piper Sandler" Maintained at Buy with Increased Target to $22 on, Tuesday, July 26th, 2022
  • Puneet Souda of "SVB Leerink" Maintained at Buy with Decreased Target to $14 on, Wednesday, May 11th, 2022
Contributing Sources